Reckitt's Bahrain Shutdown: A Geopolitical Risk Now a Supply Chain Reality

The Dettol and Nurofen manufacturer has shut down its Bahrain production facility and sent 400 Middle East-based staff home to work remotely. For Reckitt Benckiser, the Iran conflict has moved from board-level risk assessment to operational reality in less than a week. Factory closures and mass remote-working orders don't happen on a whim at FTSE 100 companies, suggesting security assessments deteriorated with alarming speed.

Chief executive Kris Licht told reporters on Tuesday that employee safety remained the company's 'overwhelming focus', though he acknowledged it was 'too early to specify' whether British consumers would face supply disruptions or price increases. The admission carries weight: Reckitt's portfolio reaches into millions of British bathrooms and medicine cabinets through Strepsils, Dettol, Gaviscon and Lemsip.

What's striking here is the speed of corporate response. The decisions suggest Reckitt's regional security assessments deteriorated rapidly enough to warrant immediate action, even as the company remains publicly circumspect about supply chain implications.

Enjoying this article?

Get stories like this in your inbox every week.

Join the Community

Compounding headwinds for investors

Investors took a dim view of the uncertainty. Shares fell 6% on Tuesday, despite Reckitt reporting pre-tax profits that nearly doubled to £3.8 billion for 2025, up from £2.1 billion the previous year. Like-for-like sales grew 5%, with underlying profits rising 5.2% to £3.3 billion on a constant currency basis.

The market reaction reflects something more fundamental than Middle East operations alone. Reckitt simultaneously warned that weak cold and flu seasons globally, combined with deteriorating European consumer confidence, would weigh on performance through early 2026.

European sales already fell 1.4% in the most recent reporting period, hit by lower demand for cold remedies and what the company termed a 'challenging consumer environment'. For a business that relies on predictable, repeat purchases of everyday essentials, the combination of geopolitical disruption and weakening consumer demand creates a particularly uncomfortable squeeze.

According to Chris Beauchamp, chief market analyst at IG, investors would be wise to treat Reckitt's forward guidance with scepticism given the likelihood of 'prices across the globe taking a big lurch higher' from Middle East instability.

Supply chain geography matters

Bahrain's significance to Reckitt extends beyond local market sales. The facility formed part of the company's regional manufacturing and distribution network, serving markets across the Gulf and potentially further afield. Pharmaceutical and consumer goods companies frequently use Middle East production hubs to supply European, Asian and African markets, taking advantage of the region's geographic position and established logistics infrastructure.

Reckitt hasn't disclosed which specific product lines the Bahrain plant produced, nor whether alternative manufacturing capacity exists elsewhere in its global network. That opacity leaves questions about which brands might face tighter supplies if the facility remains closed for an extended period.

The company's Middle East workforce of 400 represents a modest fraction of its global employee base, but the rapid shift to remote working suggests Reckitt maintains substantial commercial operations across the region beyond pure manufacturing. Distribution centres, sales operations and regulatory teams typically require on-ground presence.

Whether competitors face similar operational pressures remains unclear. Unilever and GSK both maintain significant Middle East operations for consumer goods and pharmaceutical products respectively, yet neither has publicly disclosed comparable facility closures or workforce relocations. That silence could reflect either different risk assessments, or simply more cautious corporate communications strategies.

What happens when everyday brands meet geopolitics

British households tend to notice supply chain disruption only when supermarket shelves go empty. Reckitt's products occupy the unglamorous but essential category: throat lozenges for winter colds, antiseptics for cuts, heartburn tablets for late dinners. These aren't luxury goods that consumers can easily forgo.

The company's predicament illustrates how quickly abstract geopolitical risk transforms into concrete business decisions. Last week, Iran conflict represented a line item in enterprise risk registers. This week, it means closed factories and dispersed workforces.

For Licht, the timing couldn't be worse. Taking the helm of a major consumer goods company during simultaneous European economic weakness and Middle East conflict would test any executive's crisis management skills. His cautious public statements reflect the genuine uncertainty: forecasting supply chain impacts during an active conflict requires guessing at variables no spreadsheet can model.

Whether Reckitt's Bahrain closure proves a brief precautionary measure or signals extended regional disruption will depend on how the coming weeks unfold. British consumers might not notice immediately—most companies carry inventory buffers precisely for situations like this. But if other multinationals begin making similar operational decisions, those bathroom cabinet staples could become harder to find, and more expensive to buy, before summer arrives.

More articles by Ross Williams